Venture Connection: Participant Spotlight
INDIGO Biosciences Reduces the Time and Cost of Drug Discovery
INDIGO Biosciences, Inc., founded in 2005 in State College by Dr. Jack Vanden Heuvel and Dr. Blake Peterson, is a biosciences company focused on nuclear receptors, which make up a major class of therapeutic drug targets. The company has the largest global portfolio of nuclear receptor (NR) assay kits and related screening services.
INDIGO Biosciences’ original focus was to provide custom services for the screening of small molecule compounds against functional human and non-human nuclear receptors.
Over the years, the company has demonstrated success in providing quality screening services to clients within the pharmaceutical, biotechnology, food, agriculture, and nutriceutical industries, government research agencies, as well as to academic researchers.